Gabapentin for Sleep in Critically Ill Patients

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 1, 2020

Primary Completion Date

August 4, 2023

Study Completion Date

May 30, 2025

Conditions

Intensive Care Unit Sleep Disruption

Interventions

DRUG

Gabapentin 300 mg PO at 8 PM

Administer gabapentin 300 mg PO at 8 PM for sleep

Trial Locations (1)

Tufts Medical Center, Boston

All Listed Sponsors

lead

Tufts Medical Center

OTHER

NCT04631510 - Gabapentin for Sleep in Critically Ill Patients | Biotech Hunter | Biotech Hunter